Quest Diagnostics Incorporated
DGX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $3 | $3 |
| % Growth | 2% | 4.1% | 1.2% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 33.7% | 34.2% | 32.5% | 32.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 13.7% | 15.9% | 13% | 13.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 8.7% | 10.2% | 8.3% | 8.5% |
| EPS | 2.18 | 2.51 | 1.97 | 1.98 |
| % Growth | -13.1% | 27.4% | -0.5% | – |
| EPS Diluted | 2.16 | 2.47 | 1.94 | 1.95 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $0 | $1 |
| % Margin | 19.4% | 21.6% | 18.4% | 19.3% |